Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

Lancet

Volumn 348, Issue 9035, 1996, Pages 1133-1138

  Simpson, Guy R ^a   Schulz, Thomas F ^a   Whitby, Denise ^b   Cook, Pamela M ^a   Boshoff, Chris ^b   Rainbow, Lucille ^a   Howard, Mark R ^c   Gao, Shou Jiang ^d   Bohenzky, Roy A ^d   Simmonds, Peter ^e   Lee, Christine ^f   De Ruiter, Annemiek ^g   Hatzakis, Angelos ^h   Tedder, Richard S ^c   Weller, Ian V D ^c   Weiss, Robin A ^b   Moore, Patrick S ^d  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d Columbia University ^*  (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CAPSID PROTEIN; RECOMBINANT PROTEIN;

ANTIBODY RESPONSE; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HEMOPHILIA; HERPES; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE TEST; INTRAVENOUS DRUG ABUSE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OPEN READING FRAME; PREVALENCE; PRIORITY JOURNAL; UGANDA; UNITED KINGDOM; UNITED STATES; VIRUS GENOME;

EID: 16044367614     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07560-5     Document Type: Article

References (34)

1. Beral V. Epidemiology of Kaposi's sarcoma. In: Beral V, Jaffe HW, Weiss RA, eds. Cancer, HIV and AIDS. Cancer Surv 1991; 10: 5-22. Cold Spring Harbor Laboratory Press, 1991.
2. Schulz TF, Weiss RA Kaposi's sarcoma: a finger on the culprit. Nature. 373:1995;17-18.
3. Beral V, Peterman TA, Berkelman RL, Jaffe HW. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 1990; 335: 123-28.
4. Jacobson LP, Muñoz A, Fox R, et al. Incidence of Kaposi's sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. J AIDS 1990; 3 (suppl 1): S24-31.
5. Archibald CP, Schechter MT, Craib KJP, et al. Risk factors for Kaposi's sarcoma in the Vancouver lymphadenopathy-AIDS study. J AIDS 1990; 3 (suppl 1): S18-23.
6. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-69.
7. Moore PS, Gao S-J, Dominguez G, et al. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J Virol 1996; 70: 549-58.
8. Boshoff C, Whitby D, Hatzioannou T, et al. Kaposi's sarcoma associated herpesvirus in HIV-negative Kaposi sarcoma. Lancet 1995; 345: 1043-44.
9. Lebbé C, Brendse N, Dictor Met al. Kaposi's sarcoma and new herpes virus. Lancet. 345:1995;1180.
10. Schalling M, Eukman M, Kaaya EE, et al. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995; 1: 707-08.
11. Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences are present in African endemic and AIDS-associated Kaposi's sarcoma. Arch Intern Med 1996; 156: 202-04.
12. Buonaguro FM, Tornesello ML, Beth-Giraldo Eet al. Herpes virus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer. 65:1996;25-28.
13. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181-85.
14. Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma associated herpesvirus infects endothelial and spindle cells. Nature Med 1995; 1: 1274-78.
15. Whitby D, Howard MR, Tenant-Flowers Met al. Detection of Kaposi sarcoma-associated herpesvirus (KSHV) in peripheral blood of HIV-infected individuals predicts progression to Kaposi's sarcoma. Lancet. 346:1995;799-802.
16. Moore PS, Kingsley LA, Holmberg SD, et al. KSHV infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10: 175-80.
17. Ambroziak JA, Blackburn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268: 582-83.
18. Bigoni B, Dolcetti R, de Lellis L, et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996; 173: 542-49.
19. Lin JC, Lin S-C, Mar E-C, et al. Is Kaposi's sarcoma-associated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995; 346: 1601-02.
20. Monini P, de Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334: 1168-72.
21. Li JJ, Huang YQ, Friedman-Kien AE Detection of DNA sequences of KSHV in blood, semen, KS tumor, and uninvolved skin of KS patients. AIDS Res Hum Retrovir. 11(suppl 1):1995;S98. (abstr).
22. Howard M, Whitby D, Bahadur G, et al. Detection of human herpesvirus 8 DNA in semen from HIV infected individuals and healthy semen donors. Unpublished.
23. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996; 334: 1292-97.
24. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion of antibodies to Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233-41.
25. Gao SJ, Kingsley L, Li M, et al. Seroprevalence of KSHV antibodies among North Americans, Italians, and Ugandans with and without Kaposi's sarcoma. Nature Med 1996; 2: 925-28.
26. Kedes DH, Operskalski E, Busch M, et al. The seroprevalence of human herpesvirus 8 (HHV 8): Distribution of infection in Kaposi's sarcoma risk groups and evidence for sexual transmission. Nature Med 1996; 2: 918-24.
27. Crawford DH. Epstein-Barr virus. In: Zuckerman AJ, Banatvala JE, Pattison JR, eds. Clinical virology. New York: Wiley, 1995: 109-14.
28. Horneff MW, Bein G, Fricke L, et al. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 1995; 60: 474-80.
29. van Grunsven WMJ, van Heerde EC, de Haard HJW, et al. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins. J Virol 1993; 67: 3908-16.
30. van Grunsven WMJ, Spaan JM, Middledorp JM Localisation and diagnostic application of immunodominant domains of the BFRF3-encoded Epstein-Barr virus capsid protein. J Infect Dis. 170:1994;13-19.
31. Whitby D, Hoad JG, Dillon MJet al. Isolation of measles virus from child with Kawasaki disease. Lancet. 338:1991;1215.
32. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.
33. Corey L, Spear PG. Infection with herpes simplex viruses. N Engl J Med 1986; 314: 686-91.
34. Ades AE, Peckham CS, Dale GEet al. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Commun Health. 43:1989;53-60.